SOLTI-1303 PATRICIA 2 randomized phase II trial of palbociclib plus trastuzumab and endocrine therapy (ET) versus treatment of physician's choice (TPC) in metastatic HER2-positive and hormone receptor-positive (HER2+/HR+) breast cancer (BC) with PAM50 luminal intrinsic subtype

Simple item page
dc.conference.dateMAY 05-08, 2021
dc.conference.titleESMO Breast Cancer Virtual Congress
dc.contributor.authorCiruelos, E. M.
dc.contributor.authorGarcia, A. A.
dc.contributor.authorCortes, J.
dc.contributor.authorPernas Simon, S.
dc.contributor.authorGarate, E.
dc.contributor.authorMele, M.
dc.contributor.authorMontano, A.
dc.contributor.authorMartinez-Janez, N.
dc.contributor.authorOliveira, M.
dc.contributor.authorde la Haba-Rodriguez, J.
dc.contributor.authorVega, E.
dc.contributor.authorPerello Martorell, A.
dc.contributor.authorBermejo De Las Heras, B.
dc.contributor.authorCantos Sanchez De Ibarguen, B.
dc.contributor.authorMartinez, E.
dc.contributor.authorVila Navarro, E.
dc.contributor.authorPascual, T.
dc.contributor.authorGonzalez-Farre, X.
dc.contributor.authorVillagrasa, P.
dc.contributor.authorPrat, A.
dc.contributor.authoraffiliation[Ciruelos, E. M.] Univ Hosp 12 Octubre, SOLTI Breast Canc Res Grp, Med Oncol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Garcia, A. A.] Hosp Gen Univ Alicante, Med Oncol Dept, Alicante, Spain
dc.contributor.authoraffiliation[Cortes, J.] Vall dHebron Univ Hosp, Oncol Dept, Barcelona, Spain
dc.contributor.authoraffiliation[Pernas Simon, S.] Hosp Duran & Reynals, ICO Inst Catala Oncol Hospitalet, Med Oncol Breast Unit, SOLTI Breast Canc Res Grp, Lhospitalet De Llobregat, Spain
dc.contributor.authoraffiliation[Garate, E.] Hosp Basurto, Med Oncol Dept, Bilbao, Spain
dc.contributor.authoraffiliation[Mele, M.] Hosp Univ St Joan Reus, Med Oncol Dept, Reus, Spain
dc.contributor.authoraffiliation[Montano, A.] Hosp Univ Virgen del Rocio, Med Oncol Dept, Seville, Spain
dc.contributor.authoraffiliation[Martinez-Janez, N.] Hosp Univ Ramon y Cajal, GEICAM Breast Canc Grp, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Oliveira, M.] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Breast Canc Grp, SOLTI Breast Canc Res Grp, Barcelona, Spain
dc.contributor.authoraffiliation[de la Haba-Rodriguez, J.] Hosp Univ Reina Sofia, Med Oncol, GEICAM, Spanish Breast Canc Grp, Cordoba, Spain
dc.contributor.authoraffiliation[Vega, E.] HM CIOCC, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Perello Martorell, A.] Hosp Univ Son Espases, Med Oncol Dept, Palma De Mallorca, Spain
dc.contributor.authoraffiliation[Bermejo De Las Heras, B.] Hosp Clin Univ Valencia, INCLIVA, Med Oncol, CIBERONC, Valencia, Spain
dc.contributor.authoraffiliation[Cantos Sanchez De Ibarguen, B.] Hosp Univ Puerta de Hierro Majadahonda, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Martinez, E.] Consorcio Hosp Prov Castellon, Med Oncol Dept, Castellon De La Plana, Spain
dc.contributor.authoraffiliation[Vila Navarro, E.] SOLTI Breast Canc Res Grp, Sci Dept, Barcelona, Spain
dc.contributor.authoraffiliation[Villagrasa, P.] SOLTI Breast Canc Res Grp, Sci Dept, Barcelona, Spain
dc.contributor.authoraffiliation[Pascual, T.] Hosp Clin Barcelona, Med Oncol Dept, SOLTI Breast Canc Res Grp, Barcelona, Spain
dc.contributor.authoraffiliation[Prat, A.] Hosp Clin Barcelona, Med Oncol Dept, SOLTI Breast Canc Res Grp, Barcelona, Spain
dc.contributor.authoraffiliation[Gonzalez-Farre, X.] Hosp Gen Cataluna, Inst Oncol Dr Rosell, SOLTI Breast Canc Res Grp, Med Oncol Dept, Sant Cugat Del Valles, Spain
dc.contributor.funderPfizer
dc.date.accessioned2025-01-07T13:50:20Z
dc.date.available2025-01-07T13:50:20Z
dc.date.issued2021-05-08
dc.identifier.doi10.1016/j.annonc.2021.03.144
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S092375342101022X/pdf
dc.identifier.urihttps://hdl.handle.net/10668/25898
dc.identifier.wosID648924400134
dc.issue.number2
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.page.numberS77-S77
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleSOLTI-1303 PATRICIA 2 randomized phase II trial of palbociclib plus trastuzumab and endocrine therapy (ET) versus treatment of physician's choice (TPC) in metastatic HER2-positive and hormone receptor-positive (HER2+/HR+) breast cancer (BC) with PAM50 luminal intrinsic subtype
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Reina Sofía
SAS - Hospital Universitario Virgen del Rocío

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía